BackSagimet Biosciences Overview

Sagimet Biosciences Total Assets

Sagimet Biosciences's total assets is $110M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$107.75M
↓ 26.28% YoYΔ $-38.42M vs prior year quarter

Peer average

Loading

Sagimet Biosciences Total Assets History

Loading

Sagimet Biosciences vs. peers: Total Assets Comparison

Loading

Sagimet Biosciences Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sagimet Biosciences (SGMT) FAQ

As of the most recent data (March 2026), SGMT shows a total assets of $110M. That compares with $150M in the prior-year period — down 26.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SGMT's total assets is now $110M (was $150M) — a 26.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sagimet Biosciences is outperforming or lagging.

Tracking SGMT's total assets over time shows whether Sagimet Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $110M That compares with $150M in the prior-year period — down 26.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Sagimet Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $110M) with ownership activity and broader fundamentals.